Advertisement

Topics

Clariance SAS Product Pipeline Analysis, 2017 Update [Report Updated: 01062017] Prices from USD $750

10:55 EDT 3 Jul 2017 | BioPortfolio Report Blog

Summary

Clariance SAS Clariance is a spinal device company that designs, manufactures and markets treatment systems for spinal disorders. The company provides advanced surgical applications with focus on fusion technologies and minimally invasive technologies for use by spine surgeons and interventional radiologists. Its products include IdysTLIF cage, IdysPLIF cage, ErismaLP, NeoFacet, PTLIF cage and C cage, besides percutaneous products. The company developed Platform Access, a percutaneous technique in minimally invasive surgery. It distributes its products through a network of distributors in domestic and overseas markets. The company has operations in France. It operates in the US through a subsidiary. Clariance is headquartered in Beaurains, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Clariance SAS
The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research Development strategies
Develop marketentry and market expansion strategies
Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Original Article: Clariance SAS Product Pipeline Analysis, 2017 Update [Report Updated: 01062017] Prices from USD $750

NEXT ARTICLE

More From BioPortfolio on "Clariance SAS Product Pipeline Analysis, 2017 Update [Report Updated: 01062017] Prices from USD $750"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...